|
Due to the automated manufacturing execution system (mes) there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported event could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.It was reported that there was resistance when advancing the coil inside the microcatheter.When the coil was retracted it got stretched and it prematurely detached.The coil was removed together with the microcatheter.After that, the procedure was completed successfully.No anomalies were noted to the device prior to use.Based on the additional information intermittent flush was maintained instead of the recommended continuous flush.Per the dfu, "in order to achieve optimal performance of the coil system and to reduce the risk of thromboembolic complications, it is critical that a continuous infusion of appropriate flush solution be maintained between a) the femoral sheath and guide catheter or long sheath, b) the 2-tip microcatheter and guide catheter or long sheath, and c) the 2-tip microcatheter and guidewire and delivery wire.Continuous flush also reduces the potential for thrombus formation on, and crystallization of infusate around, the detachment zone of the coil".Based on the review of all available information, an assignable cause of use error will be assigned to this event.The investigation confirms that there was an act or omission of an act that resulted in a different medical product response than intended by the manufacturer and/or expected by the user.
|